Due Diligence

Technology, market, customers, competitors, business model, regulatory strategy, reimbursement – in the life sciences, you need to go a level deeper to understand the attractiveness and positioning of your target investment. DeciBio can get you there.

Our Experts

David Cavanaugh

David Cavanaugh

Carl Schoellhammer

Carl Schoellhammer

Stephane Budel

Schedule a Call

Related Client Results

All Client Results

Clinical Diagnostics

Diagnostic Advisory Board

A diagnostics company requested DeciBio to help an advisory board (ad board) to understand how to position its relatively new somatic oncology genomics profiling product in an already competitive market

Voice-of-Customer Research

KOL Identification

Clinical Diagnostics

Genetic Testing Company Assessment

A group asked DeciBio to identify and evaluate clinical genetic testing labs for potential acquisition

Target Identification

Pharma & Biotech

Cell Therapy Market Trends and Revenue Forecast

DeciBio conducted financial projections, valuation, and assisted with messaging to aid client's public listing to NASDAQ

Revenue Projection

Clinical Diagnostics

Opportunity Assessment & Target Customer Identification for In-House Hereditary Cancer Testing

A leader in research and clinical sequencing wanted to assess the market opportunity and key customer segments for an in-house hereditary cancer testing (HCT) solution

Customer Segmentation

Voice-of-Customer Research

Market Landscaping and Sizing

Clinical Diagnostics

Infectious Pathogen Diagnostics Technology Commercialization

A major diagnostics manufacturer had developed a novel technology for the rapid detection of infectious pathogens and required assistance in developing commercialization strategy and sales tactics. DeciBio’s services were contracted to profile relevant stakeholders, characterize existing workflows and acquisition / implementation processes, and develop a product-specific launch strategy.

Voice-of-Customer Research

Clinical Diagnostics

NIPT Market Landscape and Strategy

A large multi-national diagnostic company was interested in understanding the market landscape and potential strategy for the decentralization of NIPT in the U.S.

Voice-of-Customer Research

Competitive Analysis

Customer Segmentation

Go-to-Market Strategy

Precision Medicine is evolving at a rapid pace

Discover how we can help